Prilosec OTC Lawsuit

Prilosec OTC Lawsuit

Prilosec OTC is used my (by) millions of consumers each year to treat heartburn and other conditions.

In 2010, many studies indicated an increased risk of bone fractures in the wrist, hip, and spine when Prilosec OTC was used for a long period of time. The FDA eventually determined that low dose usage of one year or less did not need a safety warning. However, dangerous side effects have recently been discovered.

Side effects include:

  • Dementia
  • Heart Attack
  • Acute interstitial nephritis (AIN)
  • Short-term kidney problems and injuries
  • Low magnesium levels
  • Stroke

JAMA recently published a study of participants taking Prilosec and other proton pump inhibitors (PPIs). The study revealed a 20-50% higher risk of chronic kidney damage compared to nonusers

Other studies have determined:

  • that use of Prilosec could lead to increased risk of gastric cancer. Risk more than doubled for patients who had previous infections in the stomach.
  • Increase of stroke by 21%
  • Increase of heart attack by 21%
  • Omeprezole use doubling senior risk of dementia with regular use

If you or someone you know has been injured by Prilosec or other Proton Pump Inhibitors, contact Daniel & Associates for a consultation.

Related Sources:1 Chase R. AstraZeneca to pay $7.9 million over kickback allegations. Boston Globe. February 11, 2015.
2 Cheung K, Chan E, et al. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study. Gut. 2018;67:28-35.
3 Lazarus B, Chen Y, et al. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. JAMA Internal Medicine. 2016;176(2):238-246. doi:10.1001/jamainternmed.2015.7193
4 Shah N, LePendu P, et al. Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population. Plos One. June 2015. doi: 10.1371/journal.pone.0124653
5 U.S. Food and Drug Administration. FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors. March 2011.
6 U.S. Food and Drug Administration. Prilosec OTC (omeprazole) Information. November 2015.
7 U.S. Food and Drug Administration. Questions and Answers on Prilosec OTC (omeprazole). November 2015.
8 United States Judicial Panel on Multidistrict Litigation. MDL Statistics Report – Distribution of Pending MDL Dockets by District. May 15, 2018.
9 U.S. District Court, District of New Jersey. Proton-Pump MDL 2789.
10 Xie Y, Bowe B, et al. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD. Journal of the American Society of Nephrology. 2016 Oct;27(10):3153-3163.
2018-12-06T06:26:44+00:00